Division of Biotechnology and Plant Health
GreenVac
Development of a cost-effective Romania-Norway joint plant-based technology platform for production of vaccines against human hepatitis viruses B (HBV) and C (HCV)
NIBIO is a project driven research institute and collects approximately 400 million NOK annually in project funding from both national and international sources. A lot of activity is carried out through EU and EEA-projects and we also participate in research projects in Asia, Africa and Latin America. NIBIO coordinates several large international projects with a particular focus on food security and climate change. The list of projects is not complete.
Development of a cost-effective Romania-Norway joint plant-based technology platform for production of vaccines against human hepatitis viruses B (HBV) and C (HCV)